Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELENA: Oral Contraceptives in SLE
NCT00000420Phase 3Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ethinyl estradiol + norethindrone in pregnancy (2 arms), sponsored by NYU Langone Health. Primary endpoint: Severe lupus flare rate at 12 months. Started Jun 1997; status: completed.
02
Drugs
ethinyl estradiol + norethindrone
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00000420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000420.